AXT (AHV) AI Stock Analysis

AXT

(XETRA:AHV)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Indium Phosphide DemandA backlog above $500 million, together with demand exceeding available supply, indicates substantial customer need for AXT’s materials over multiple periods. This supports revenue visibility and provides a durable platform for capacity expansion, particularly as indium phosphide demand grows in optical connectivity.

Negative Factors

Negative Cash GenerationNegative operating and free cash flow indicate that recent reported profitability has not yet translated into internally generated cash. Continued cash consumption could constrain funding flexibility, increase reliance on financing or customer prepayments, and make the current earnings recovery less durable.

AXT (AHV) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 3.61B
Dividend Yield: ―
Average Volume (3M): 4,315
Price to Earnings (P/E): 117.5
Beta (1Y): 1.16
Revenue Growth: 80.58%
EPS Growth: ―
Country: Germany
Employees: 1,541
Sector: Technology
Sector Strength: 61
Industry: Semiconductors

AXT Business Overview & Revenue Model

Company Description

AXT, Inc. is a company dedicated to the design, development, production, and worldwide distribution of both compound and single-element semiconductor substrates. Leveraging its proprietary vertical gradient freeze technology, the firm manufactures th...

AXT Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:-14.87%|Next Earnings Date:Feb 17, 2027

Earnings Call SentimentPositive

The call was strongly positive, characterized by record revenue, substantial gross margin expansion, a return to significant profitability, rising backlog above $500 million, demand that exceeds supply, and continued capacity expansion tied to AI infrastructure. The company also provided strong Q4 earnings guidance and expects further gross margin improvement. The main challenges were higher operating expenses, a $2.7 million below-the-line loss, rising raw material prices, seasonal Q4 declines in some gallium arsenide applications, customer concentration, and the execution demands associated with rapidly scaling capacity.

Positive Updates

Record Revenue Growth

Q3 2026 revenue was $73.4 million, up 54% from $47.6 million in Q2 2026 and up 162% from $28.0 million in Q3 2025.

Negative Updates

Operating Expenses Increased

Q3 non-GAAP operating expense was $11.7 million, up from $10.2 million in Q2 2026 and $6.7 million in Q3 2025. GAAP operating expense was $12.7 million, compared with $10.9 million in Q2 2026 and $7.3 million in Q3 2025.

Company Guidance

For Q4, AXT has approximately $90 million in revenue that can be realized across substrate product lines and raw materials, with a high degree of confidence in recognizing this revenue, and Tim Bettles said total projection of Q4 being around the $90 million mark, with all of the growth going to be indium phosphide. Non-GAAP operating expense is expected to be approximately $13 million and GAAP operating expense approximately $14 million; non-GAAP net income is expected to be in the range of $0.57 to $0.59 and GAAP net income in the range of $0.56 to $0.58, with Q4 share count estimated at approximately 66.1 million shares. Gary Fischer said gross margin could begin with a 6 in the next quarter, not a high 6, and later said it is pretty obvious that AXT is going to cross over 60%, while Morris Young said 6-inch is going to be single digit for 2027. AXT expects to be at 2.75 or 3 at the end of 2026 relative to end of 2025 as one for indium phosphide capacity, with a goal to double again in 2027.

AXT Risk Analysis

AXT disclosed 64 risk factors in its most recent earnings report. AXT reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.Certain Investors of Tongmei have a right of redemption as a result of Tongmei's withdrawal of the IPO application.Q2, 2026

2.For as long as we are a "smaller reporting company," we may take advantage of certain scaled disclosures available to Us and will be eligible to rely on reduced disclosure and reporting requirements applicable to smaller reporting companies.Q2, 2026

3.We may not achieve the revenues we expect under our long term supply agreement with our customers.Q2, 2026

AXT Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:AHV against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NVEC	75Outperform	$375.80M	20.97	30.52%	5.16%	24.06%	29.27%
Sector *	61Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
XPER	59Neutral	$259.95M	-7.60	-7.84%	―	-3.87%	-946.99%
MRAM	53Neutral	$331.40M	-33.97	-14.09%	―	28.74%	-1527.71%
VLN	52Neutral	$163.50M	-4.84	-31.56%	―	7.68%	0.83%
ATOM	44Neutral	$130.73M	-5.32	-70.93%	―	476.32%	6.65%

* Technology Sector Average

Performance Comparison

DE:AHV and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:AHV	AXT Inc	47.16	40.03	561.89%
NVEC	NVE Corporation	77.58	14.14	22.30%
ATOM	Atomera Inc	3.35	0.51	17.96%
MRAM	Everspin Technologies Inc	13.61	3.76	38.17%
VLN	Valens	1.51	-0.08	-5.03%
XPER	Xperi Inc	5.33	-1.04	-16.33%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

AXT AI Stock Analysis